You are here:

Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer.

Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, Agerbæk M, Høyer M.
Acta Oncol. 2014 Aug;53(8):997-1004.

Link PubMed